Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elder Pharma to launch 35 products in 30 months
Business Standard, India
Saturday, June 11, 2011 - 2:38pm
tags:
Elder Pharmaceuticals
Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
MedIndia, India
Saturday, June 11, 2011 - 2:36pm
tags:
Aurobindo, ramipril, generics
Eli Lilly insulin brand paves way for hike in imported drug prices (in India)
Economic Times, India
Saturday, June 11, 2011 - 12:29pm
tags:
Eli Lilly, insulin, diabetes
Novo Nordisk Agrees to $1.7M Settlement for Medicaid Fraud
MyFox Tampa Bay, FL
Saturday, June 11, 2011 - 12:27pm
tags:
Novo Nordisk, legal
Biogen Readies New Plants And Tech In Advance
Investors
Saturday, June 11, 2011 - 11:12am
tags:
Biogen Idec
Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
Street Insider
Saturday, June 11, 2011 - 11:01am
tags:
Bristol-Myers Squibb, Pfizer, Big Pharma, pipelines
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
Saturday, June 11, 2011 - 10:58am
tags:
systemic anaplastic large cell lymphoma, Seattle Genetics, Millennium, Adcetris
Breckenridge Announces Approval of Generic Activella® 0.5mg/0.1mg Tablets
PR NewsWire
Saturday, June 11, 2011 - 10:56am
tags:
Breckenridge, Activella, generics
Bristol-Myers Squibb's Dividend Is Safe
Motley Fool
Saturday, June 11, 2011 - 10:45am
tags:
Bristol-Myers Squibb
Merck revises drug labels to cut dispensing errors
Yahoo/AP
Saturday, June 11, 2011 - 10:44am
tags:
Merck
Merck, Partner Suspend Study
Yahoo/Zacks
Saturday, June 11, 2011 - 10:43am
tags:
Merck, Intercell, V710, staphylococcus aureus
Vertex Presents Data on CF Drug
Yahoo/Zacks
Saturday, June 11, 2011 - 10:41am
tags:
Vertex Pharmaceuticals, cystic fibrosis
Abbott Picks Pumps Over Pills
Motley Fool
Saturday, June 11, 2011 - 10:40am
tags:
Abbott Laboratories, Parkinson's Disease
Novartis Bexsero Vaccine Encourages
Yahoo/Zacks
Saturday, June 11, 2011 - 10:38am
tags:
Bexsero, Novartis, bacterial meningitis, meningitis
Update on Forest's Daliresp
Yahoo/Zacks
Saturday, June 11, 2011 - 10:34am
tags:
Forest Labs, Daliresp, COPD
Is Amgen the Right Stock to Retire With?
Motley Fool
Saturday, June 11, 2011 - 10:33am
tags:
Amgen
Lipitor: Pfizer's Loss Is Watson's Gain
Investopedia
Saturday, June 11, 2011 - 10:32am
tags:
Pfizer, Lipitor, Watson Pharmaceuticals
Gilead Drops After-Hours on Subpoena Disclosure
Barron's
Saturday, June 11, 2011 - 10:28am
tags:
Gilead Sciences, legal
Bayer Seeks European Approval
Yahoo/Zacks
Saturday, June 11, 2011 - 10:27am
tags:
Bayer, VEGF Trap-Eye, age-related macular degeneration
Great Data! Now Lets See More Than 12 Patients
Motley Fool
Saturday, June 11, 2011 - 10:25am
tags:
Micromet, leukemia, blinatumomab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.